<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sat, 05 Dec 2009 17:52:35 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Weekly Mergers and Acquisitions Report - Aug  5 2008  5:37PM</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2479309</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (APPX) - Fresenius, Allied Waste Industries (AW) - Republic Services, Inc. (RSG), Alpha Natural Resources, Inc. (ANR) - Cleveland-Cliffs Inc (CLF)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2479309>[More...]</a>]]></description>
      <pubDate>Tue, 05 Aug 2008 21:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ANR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EDS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FLI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RSG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2479309</link>
    </item>
    <item>
      <title>Mergers and Acquisitions Report: CHC Helicopter, APP Pharmaceuticals, Take-Two Interactive, ProCentury Corp, Anheuser-Busch, Rio Tinto</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2385552</guid>
      <description><![CDATA[FLI has announced Industry Canada approval of this transaction.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2385552>[More...]</a>]]></description>
      <pubDate>Thu, 10 Jul 2008 19:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BHP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BUD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ERTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FLI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PROS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RTP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TTWO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2385552</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Announces Trading Information on NASDAQ of Contingent Value Rights Associated with the Acquisition by Fresenius</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2601532</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc., formerly traded on the NASDAQ Capital Market under the symbol APPX, today announced that the NASDAQ Global Market has accepted for listing the Contingent Value Rights (CVRs) related to the acquisition of APP by Fresenius Kabi, a business segment of Fresenius SE. The CVRs will trade under the symbol “APCVZ” beginning on Thursday, September 11, 2008.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2601532>[More...]</a>]]></description>
      <pubDate>Wed, 10 Sep 2008 22:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2601532</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Announces Completion of Acquisition by Fresenius - Sep 10 2008 12:44PM</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2599833</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc., formerly traded on the NASDAQ Capital Market under the symbol APPX, today announced that Fresenius Kabi, a business segment of Fresenius SE, has completed its acquisition of APP. The official close date is September 10, 2008.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2599833>[More...]</a>]]></description>
      <pubDate>Wed, 10 Sep 2008 16:31:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2599833</link>
    </item>
    <item>
      <title>APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2568940</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX) and Fresenius SE (XETRA:FRE) have received confirmation that the U.S. Federal Trade Commission (FTC) has completed its review of the proposed acquisition of APP Pharmaceuticals by Fresenius Kabi, a business segment of Fresenius SE. The FTC granted early termination of the waiting period under the Hart-Scott-Rodino Act without conditions. The German antitrust authorities had already approved the acquisition.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2568940>[More...]</a>]]></description>
      <pubDate>Tue, 02 Sep 2008 15:24:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2568940</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2523987</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq: APPX), a leading provider of hospital-based injectable pharmaceutical products, today said that the U.S Food and Drug Administration (FDA) has approved APP’s manufacturing facility in Barceloneta, Puerto Rico for the manufacture of three product codes of Heparin Sodium Injection, USP.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2523987>[More...]</a>]]></description>
      <pubDate>Mon, 18 Aug 2008 20:54:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2523987</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Reports 2008 Second Quarter Net Revenues of $198 Million, Operating Income of $53 Million</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2461481</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today reported financial results for the second quarter and six months ended June 30, 2008. As a result of the separation of Abraxis BioScience from APP Pharmaceuticals in the fourth quarter of 2007, APP’s business is reported, for all periods presented, on a continuing operations basis.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2461481>[More...]</a>]]></description>
      <pubDate>Fri, 01 Aug 2008 00:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2461481</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Announces Date for 2008 Second Quarter Financial Results and Investor Conference Call</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2433909</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced it will release its 2008 second quarter financial results after the market closes on Thursday, July 31, 2008. The Company also said that senior management will host an investor conference call on Friday, August 1, 2008 at 7:00 a.m. PT/10:00 a.m. ET to review the company’s financial results.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2433909>[More...]</a>]]></description>
      <pubDate>Thu, 24 Jul 2008 20:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2433909</link>
    </item>
    <item>
      <title>APP Pharmaceuticals to Be Acquired by Fresenius</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2375177</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading provider of hospital-based injectable pharmaceutical products, and Fresenius SE (XETRA:FRE), a global health care group with approximately $18 billion of sales in products and services for hospital, dialysis and in home medical care, today announced that they have entered into a definitive merger agreement pursuant to which Fresenius will acquire APP.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2375177>[More...]</a>]]></description>
      <pubDate>Mon, 07 Jul 2008 04:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2375177</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2371117</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Granisetron Hydrochloride Injection, 1 mg/mL, 1 mL single dose, and 1mg/mL, 4mL multiple dose vials, the generic equivalent of Hoffmann-LaRoche’s Kytril&#174; Injection. According to IMS data, branded sales of these two dosage forms of Granisetron were approximately $72.2 million in 2007. The company currently markets Granisetron in 0.1 mg/mL, 1 mL single dose vials and will commence distributing the 1 mg/mL, 1 mL single dose, and 1mg/mL, 4 mL multiple dose vials immediately. All of APP’s Granistron products are AP-rated, preservative and latex-free, and bar-coded.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2371117>[More...]</a>]]></description>
      <pubDate>Thu, 03 Jul 2008 11:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2371117</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2244218</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq:APPX) today announced the launch of enhanced labeling for its line of Heparin Sodium Injection, USP. The labels and cap colors for APP’s heparin have incorporated clearly differentiating color combinations since the company began marketing the product in 1998. Also, the current product’s labels include bar codes at the individual unit-of-use. APP’s new labeling represents further enhancements to help differentiate Heparin Sodium from other heparin products, including Heparin Lock Flush Solution, USP. As part of the company’s long-standing commitment to patient care and in response to concerns regarding a higher risk of medication errors associated with heparin, the new labeling will further help healthcare professionals quickly identify the correct drug and ultimately administer the proper dose.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2244218>[More...]</a>]]></description>
      <pubDate>Mon, 02 Jun 2008 15:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2244218</link>
    </item>
    <item>
      <title>APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply - May 27 2008 12:53AM</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1952610</guid>
      <description><![CDATA[APP Pharmaceuticals, Inc. (Nasdaq: APPX) is communicating in a letter to its customers that the company continues to work closely with the U.S. Food and Drug Administration (FDA) to ensure that an uninterrupted and safe supply of heparin of the highest quality is available for U.S. patients.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1952610>[More...]</a>]]></description>
      <pubDate>Thu, 15 May 2008 10:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1952610</link>
    </item>
    <item>
      <title>Form  4          DePina Stuart             For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616335</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616335>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616335</link>
    </item>
    <item>
      <title>Form  4          BLASZYK MICHAEL D         For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616336</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616336>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616336</link>
    </item>
    <item>
      <title>Form  4          SITRICK MICHAEL S         For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616337</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616337>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616337</link>
    </item>
    <item>
      <title>Form  4          Pizza Joseph M            For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616338</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616338>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:53:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616338</link>
    </item>
    <item>
      <title>Form  4          APP Pharmaceuticals,      For: Sep 10  Filed by: California Capital Limited Partnership (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616286</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616286>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616286</link>
    </item>
    <item>
      <title>Form  4          APP Pharmaceuticals,      For: Sep 10  Filed by: Themba 2005 Trust II (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616287</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616287>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616287</link>
    </item>
    <item>
      <title>Form  4          APP Pharmaceuticals,      For: Sep 10  Filed by: Themba 2005 Trust I (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616288</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616288>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616288</link>
    </item>
    <item>
      <title>Form  4          SOON SHIONG PATRICK       For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616290</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616290>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616290</link>
    </item>
    <item>
      <title>Form  4          Tajak Richard J.          For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616292</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616292>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616292</link>
    </item>
    <item>
      <title>Form  4          Silberg Thomas            For: Sep 10 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2616249</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2616249>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 00:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APPX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2616249</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=APPX" rel="self" type="application/rss+xml" />
  </channel>
</rss>